Refine your search

Content type
Firm name

412 results found

Ask Lexy

Fasken | Canada | 27 Mar 2023

French Language Requirements: Quebec Publishes Long-Awaited Draft Regulation on Documents Used in Research

The National Assembly adopted Bill 96, An Act respecting French, the official and common language of Québec on May 24, 2022, ushering in new…
Ask Lexy

Shearman & Sterling LLP | USA | 24 Mar 2023

Southern District Of New York Grants Pharmaceutical Company’s Motion To Dismiss Putative Class Action Alleging Misrepresentations About Contingent Value Right Securities

On March 1, 2023, Judge Jesse Furman of the United States District Court for the Southern District of New York granted a motion to dismiss a putative…
Ask Lexy

Fasken | Canada | 23 Mar 2023

PAAB Publishes Draft Guidance Document on Use of Real-World Evidence in Advertising

The Pharmaceutical Advertising Advisory Board (“PAAB”) has published a draft guidance document on the use of real-world evidence (“RWE”) in…

McGuireWoods LLP | USA | 20 Mar 2023

Strong margins and recession resistant: the allure of pharma services

The pharmaceutical services industry has piqued the interest of private equity investors over the last five to 10 years as more drugs move into…
Ask Lexy

Edgeworth Economics | USA | 15 Mar 2023

Don’t Count Out Numerosity

To obtain class certification, the Supreme Court of the United States requires a rigorous analysis under Rule 23. Economists can provide…
Ask Lexy

King & Wood Mallesons | China | 14 Mar 2023


Analysis PRO In-house
Ask Lexy

Lexology PRO | Central & South America, Chile | 13 Mar 2023

Chile seeks fine against immunity applicant for compliance programme failure

Chile’s antitrust watchdog has urged the country’s specialist competition tribunal to fine a drugmaker €1.3 million for breaching the terms of its compliance programme commitment after blowing the whistle on a 14-year bid-rigging scheme.
Ask Lexy

Taylor Wessing | European Union | 13 Mar 2023

Judgment of the General Court of 30 November 2022 — Hasco TM v EUIPO — Esi (NATURCAPS)

The use of a trademark for food supplements does not qualify as genuine use for pharmaceutical products according to the General Court (EU) After a…
Ask Lexy

Bass Berry & Sims PLC | USA | 9 Mar 2023

OIG Approves Free Drug Program for Ultra-Rare Condition in Advisory Opinion 23-02

On February 23, the Office of Inspector General (OIG) of the U.S. Department of Health and Human Services issued Advisory Opinion 23-02, approving a…
Ask Lexy

Bristows | European Union, United Kingdom | 7 Mar 2023

EU and UK reach new agreement on medicines regulation in Northern Ireland

The EU and UK have agreed major changes to the regulation of medicines in Northern Ireland (NI). The package of measures would simplify marketing…
Previous page 1 2 3 ...